Is Brookfield (BN) Halal?
Verdict: No — Brookfield fails Shariah screening as of September 2026. Its consolidated debt is about 316% of its market cap — nearly ten times the 33% ceiling — and its conventional insurance arm adds a second, independent problem. Zoya's screener independently rates BN non-compliant. Below: the screening math, the honest caveats, and what to hold instead.
Screen 1: Business activity — a genuine question mark
Brookfield Corporation is an alternative asset manager: it owns roughly three-quarters of Brookfield Asset Management, plus renewable power, infrastructure, private equity, and real estate operating businesses — and Brookfield Wealth Solutions, a conventional insurance/annuity business with about $157B in assets (2025: $5.3B in net premiums plus $5.9B in net investment income).
Conventional insurance is normally a prohibited business activity, and the insurance segment represents roughly 15% of consolidated revenue — above the 5% tolerance. That makes this a genuine step-one question that would need scholar-level judgment even if the debt picture were different. The debt picture, as it happens, settles the matter on its own.
Screen 2: Financial ratios — where it fails
AAOIFI-style screening applies three ratio tests:
| Ratio | Brookfield (Sept 2026) | Ceiling | Result |
|---|---|---|---|
| Total debt ÷ market cap | ~316% (C$367.6B consolidated debt on C$116.4B market cap) | < 33% | FAIL |
| Cash + interest-bearing securities ÷ market cap | 19.8% (C$23.0B cash on C$116.4B market cap) | < 30% | PASS |
| Non-compliant income ÷ total revenue | ≈ 0% (no interest income disclosed; $0 per Zoya, on $75.1B FY2025 revenue) | < 5% | PASS |
Figures: FY2025 (year ended December 31, 2025, USD millions converted at ~1.416); market data September 2026 (C$116.4B CAD market cap). Debt is the consolidated figure ($259.6B USD) from Brookfield's own annual report — the standard basis screeners use.
Screen 3: Purification — doesn't apply
Purification is for compliant holdings that earn small, incidental amounts of non-compliant income. It does not apply to a non-compliant holding: you don't purify a prohibited position, you don't hold it. Brookfield's dividend — US$0.07/quarter, roughly 0.6% yield — can't be "purified" into permissibility.
What about Brookfield Asset Management (BAM)?
BAM is a separately listed entity and would need its own screen — its financials differ structurally from the parent's consolidated holding-company statements. We haven't screened BAM yet; it's on the list. Don't assume the parent's verdict transfers to the subsidiary (or vice versa).
What to hold instead
If Brookfield was your Canadian compounder, the halal replacements are screened equities and halal ETFs — not another leveraged holding company:
- Screened individual stocks — run every candidate through Zoya before buying, the way our Constellation Software verdict (PASS), Apple verdict (PASS), and Shopify verdict (PASS) demonstrate.
- Halal ETFs — our SPUS vs HLAL vs WSHR comparison covers the Canadian-accessible options, including WSHR in CAD with no FX drag.
- The full workflow — screen → buy in a self-directed account → re-screen annually, as laid out in our complete guide.
What could change the verdict
Honestly: a fundamental restructuring — the consolidated leverage coming down by an order of magnitude, or the insurance arm being separated from the corporation. Neither is on the horizon; leverage is the business model here. We still re-check on our quarterly cadence and will update this page if the capital structure changes materially.
FAQ
Is Brookfield halal to invest in?
As of September 2026: no. Brookfield's consolidated debt is ~316% of its market cap against the 33% ceiling — the ratio screen fails by an order of magnitude. Its conventional insurance/annuity arm adds a second, independent business-screen question. Zoya's screener independently rates BN non-compliant. This is a screening result, not a religious ruling.
Only 6% of Brookfield's debt has recourse to the corporation — shouldn't the screen use corporate-only debt?
It's a fair question, and the honest answer is that screeners don't work that way. Brookfield controls and consolidates these entities, its own annual report presents $259.6B in consolidated borrowings, and screeners (Zoya included) screen consolidated statements. Using corporate-only borrowings ($14.3B, ~17.4%) would be cherry-picking — inconsistent with how the industry screens holding companies.
What about Brookfield's insurance business?
Brookfield Wealth Solutions is a conventional insurance/annuity business with ~$157B in assets, contributing roughly 15% of consolidated revenue — above the 5% tolerance. Conventional insurance is normally a prohibited business activity, so this is a genuine step-one question that would need scholar-level judgment even if the debt picture were different.
What about Brookfield Asset Management (BAM), the separately listed manager?
BAM is a separately listed entity and would need its own screen — its financials differ structurally from the parent's consolidated holding-company statements. We haven't screened BAM yet; it's on the list. Don't assume the parent's verdict transfers to the subsidiary.
I already own BN shares. What should I do?
The common guidance in screening methodologies is to exit the position. Scholars differ on timing — immediately vs. waiting to avoid a loss — and on how to handle dividends already received. Those are personal-ruling questions for a qualified scholar, not for a website. Don't offset other gains against the position, and re-screen whatever you replace it with.
The dividend is tiny — can't I just purify it and keep holding?
No. Purification applies to compliant holdings with incidental non-compliant income, not to non-compliant holdings. The standard screening-methodology guidance for a stock that fails is not to hold it — the size of the dividend doesn't change the screen.